Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €140.00 | €228.30 | 63.071% |
| Neurocrine Bioscience | 26 | 0 | 7 | 0 | €130.30 | €140.34 | 7.705% |
| Icon plc | 18 | 0 | 6 | 0 | €280.90 | €318.99 | 13.562% |
| United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.40 | €82.93 | 105.275% |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | €37.15 | €53.50 | 43.998% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.80 | €34.08 | 49.477% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €364.50 | €421.61 | 15.667% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.35 | €65.00 | -2.035% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 13 | 6 | 2 | 1 | €29.80 | €41.51 | 39.304% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.30 | €45.10 | 146.421% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.83 | €35.99 | 16.722% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.55 | €3.70 | 138.402% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.82 | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €132.00 | €150.00 | 13.636% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €99.70 | - | - |